233 related articles for article (PubMed ID: 18271914)
21. Medical risk in patients with bipolar disorder and schizophrenia.
Newcomer JW
J Clin Psychiatry; 2006 Nov; 67(11):e16. PubMed ID: 17201046
[TBL] [Abstract][Full Text] [Related]
22. Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians.
Fagiolini A; Frank E; Scott JA; Turkin S; Kupfer DJ
Bipolar Disord; 2005 Oct; 7(5):424-30. PubMed ID: 16176435
[TBL] [Abstract][Full Text] [Related]
23. Modal subcomponents of metabolic syndrome in patients with bipolar disorder.
Cardenas J; Frye MA; Marusak SL; Levander EM; Chirichigno JW; Lewis S; Nakelsky S; Hwang S; Mintz J; Altshuler LL
J Affect Disord; 2008 Feb; 106(1-2):91-7. PubMed ID: 17628693
[TBL] [Abstract][Full Text] [Related]
24. Comparison of insulin resistance, metabolic syndrome and adiponectin in overweight bipolar patients taking sodium valproate and controls.
Elmslie JL; Porter RJ; Joyce PR; Hunt PJ; Shand BI; Scott RS
Aust N Z J Psychiatry; 2009 Jan; 43(1):53-60. PubMed ID: 19085528
[TBL] [Abstract][Full Text] [Related]
25. The impact of the metabolic syndrome on the patients with acute coronary syndrome.
Agoşton-Coldea L; Mocan T; Rusu LD; Pais R; Albu A; Rusu ML; Perna S
Rom J Intern Med; 2008; 46(1):55-62. PubMed ID: 19157271
[TBL] [Abstract][Full Text] [Related]
26. Does the new International Diabetes Federation definition of metabolic syndrome improve prediction of coronary artery disease and carotid intima-media thickening?
Timóteo A; Santos R; Lima S; Mamede A; Fernandes R; Ferreira R
Rev Port Cardiol; 2009 Feb; 28(2):173-81. PubMed ID: 19438152
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic drug and cardiovascular disease risk monitoring in patients with bipolar disorder.
Kilbourne AM; Post EP; Bauer MS; Zeber JE; Copeland LA; Good CB; Pincus HA
J Affect Disord; 2007 Sep; 102(1-3):145-51. PubMed ID: 17276514
[TBL] [Abstract][Full Text] [Related]
28. Metabolic syndrome in a French cohort of patients with bipolar disorder: results from the FACE-BD cohort.
Godin O; Etain B; Henry C; Bougerol T; Courtet P; Mayliss L; Passerieux C; Azorin JM; Kahn JP; Gard S; Costagliola D; Leboyer M;
J Clin Psychiatry; 2014 Oct; 75(10):1078-85; quiz 1085. PubMed ID: 25373115
[TBL] [Abstract][Full Text] [Related]
29. Comparison of definitions of the metabolic syndrome in adult Asian Indians.
Wasir JS; Misra A; Vikram NK; Pandey RM; Gupta R
J Assoc Physicians India; 2008 Mar; 56():158-64. PubMed ID: 18697631
[TBL] [Abstract][Full Text] [Related]
30. Assessment of a point-of-care metabolic risk screening program in outpatients receiving antipsychotic agents.
Schneiderhan ME; Batscha CL; Rosen C
Pharmacotherapy; 2009 Aug; 29(8):975-87. PubMed ID: 19637951
[TBL] [Abstract][Full Text] [Related]
31. Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with second generation antipsychotics.
Vuksan-Ćusa B; Jakovljević M; Sagud M; Mihaljević Peleš A; Marčinko D; Topić R; Mihaljević S; Sertić J
Psychiatry Res; 2011 Aug; 189(1):21-5. PubMed ID: 21216014
[TBL] [Abstract][Full Text] [Related]
32. Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey.
Kjeldsen SE; Naditch-Brule L; Perlini S; Zidek W; Farsang C
J Hypertens; 2008 Oct; 26(10):2064-70. PubMed ID: 18806632
[TBL] [Abstract][Full Text] [Related]
33. C-reactive protein and metabolic syndrome in patients with bipolar disorder compared to patients with schizophrenia.
Vuksan-Cusa B; Sagud M; Jakovljević M
Psychiatr Danub; 2010 Jun; 22(2):275-7. PubMed ID: 20562761
[TBL] [Abstract][Full Text] [Related]
34. The metabolic syndrome among patients undergoing cardiac catheterization in Jordan.
Khader Y; Khatatbeh M; El-Salem K; Amarin Z; Bateiha A
J Cardiometab Syndr; 2008; 3(4):224-8. PubMed ID: 19040591
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of metabolic syndrome among an Iranian cohort of inpatients with schizophrenia.
Rezaei O; Khodaie-Ardakani MR; Mandegar MH; Dogmehchi E; Goodarzynejad H
Int J Psychiatry Med; 2009; 39(4):451-62. PubMed ID: 20391865
[TBL] [Abstract][Full Text] [Related]
36. The association between HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia.
Mulder H; Franke B; van der-Beek van der AA; Arends J; Wilmink FW; Scheffer H; Egberts AC
J Clin Psychopharmacol; 2007 Aug; 27(4):338-43. PubMed ID: 17632216
[TBL] [Abstract][Full Text] [Related]
37. Side effects as influencers of treatment outcome.
Sharif Z
J Clin Psychiatry; 2008; 69 Suppl 3():38-43. PubMed ID: 18533761
[TBL] [Abstract][Full Text] [Related]
38. The prevalence of the metabolic syndrome in patients with schizoaffective disorder--bipolar subtype.
Basu R; Brar JS; Chengappa KN; John V; Parepally H; Gershon S; Schlicht P; Kupfer DJ
Bipolar Disord; 2004 Aug; 6(4):314-8. PubMed ID: 15225149
[TBL] [Abstract][Full Text] [Related]
39. Epidemiology of metabolic syndrome in Asia.
Pan WH; Yeh WT; Weng LC
Asia Pac J Clin Nutr; 2008; 17 Suppl 1():37-42. PubMed ID: 18296297
[TBL] [Abstract][Full Text] [Related]
40. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome.
Cussons AJ; Watts GF; Burke V; Shaw JE; Zimmet PZ; Stuckey BG
Hum Reprod; 2008 Oct; 23(10):2352-8. PubMed ID: 18635531
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
